深部静脈血栓症は、体の奥深くにある静脈にできる血栓のことです。主に下腿や大腿の太い静脈に発生します。症状としては、皮膚の色の変化（赤み）、脚の痛み、脚の腫れ（浮腫）、触ると温かいと感じる皮膚などがあります。素因は、年齢、喫煙、血液凝固異常の遺伝、けがや手術、癌、炎症性腸疾患、心不全などです。治療には、血栓溶解薬、抗凝固薬などがあります。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Deep Vein Thrombosis (DVT) - Overview
Deep Vein Thrombosis (DVT) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Deep Vein Thrombosis (DVT) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Deep Vein Thrombosis (DVT) - Companies Involved in Therapeutics Development
Anthos Therapeutics Inc
Bio-Synectics Inc
CarboMimetics
China Resources Emde Biological Pharmaceutical Co Ltd
Glycan Therapeutics Inc
Guangzhou Dazhou Biomedical Technology Co Ltd
Kolmar Korea Co Ltd
Laboratorios Farmaceuticos Rovi SA
Marizyme Inc
Protheragen Inc
Suzhou Ribo Life Sciences Co Ltd
Tianjin Pharmaceuticals Group Co Ltd
Deep Vein Thrombosis (DVT) - Drug Profiles
abelacimab - Drug Profile
Product Description
Mechanism Of Action
History of Events
CM-20201 - Drug Profile
Product Description
Mechanism Of Action
enoxaparin sodium - Drug Profile
Product Description
Mechanism Of Action
History of Events
heparin - Drug Profile
Product Description
Mechanism Of Action
KKM-183A - Drug Profile
Product Description
Mechanism Of Action
MB-104 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Polysaccharide to Inhibit Coagulation Factor X for Deep Vein Thrombosis and Sickle Cell Disease - Drug Profile
Product Description
Mechanism Of Action
History of Events
reteplase - Drug Profile
Product Description
Mechanism Of Action
rivaroxaban - Drug Profile
Product Description
Mechanism Of Action
Small Molecule to Inhibit NMMHC IIA for Deep Vein Thrombosis - Drug Profile
Product Description
Mechanism Of Action
SR-059 - Drug Profile
Product Description
Mechanism Of Action
Zifa-01 - Drug Profile
Product Description
Mechanism Of Action
Deep Vein Thrombosis (DVT) - Dormant Projects
Deep Vein Thrombosis (DVT) - Discontinued Products
Deep Vein Thrombosis (DVT) - Product Development Milestones
Featured News & Press Releases
Sep 19, 2018: ROVI has commenced the marketing of its enoxaparin biosimilar in Spain
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Deep Vein Thrombosis (DVT), 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Anthos Therapeutics Inc, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Bio-Synectics Inc, 2022
Deep Vein Thrombosis (DVT) - Pipeline by CarboMimetics, 2022
Deep Vein Thrombosis (DVT) - Pipeline by China Resources Emde Biological Pharmaceutical Co Ltd, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Glycan Therapeutics Inc, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Guangzhou Dazhou Biomedical Technology Co Ltd, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Kolmar Korea Co Ltd, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Laboratorios Farmaceuticos Rovi SA, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Marizyme Inc, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Protheragen Inc, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Suzhou Ribo Life Sciences Co Ltd, 2022
Deep Vein Thrombosis (DVT) - Pipeline by Tianjin Pharmaceuticals Group Co Ltd, 2022
Deep Vein Thrombosis (DVT) - Dormant Projects, 2022
Deep Vein Thrombosis (DVT) - Dormant Projects, 2022 (Contd..1)
Deep Vein Thrombosis (DVT) - Discontinued Products, 2022
List of Figures
Number of Products under Development for Deep Vein Thrombosis (DVT), 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022
